While both are sterile and have similar uses, they have different indications and demographics
GLP-1 and GIP/GLP-1 drugs have strong Phase 3 efficacy and clear FDA-approved labels for weight management
PMCID: PMC7714782
Reconstitution Troubleshooting Quality Verification Checklist Before using reconstituted IGF-1 LR3 in experiments: [ ] Confirm lot certificate of analysis (HPLC purity 98%, mass spec identity) [ ] Document reconstitution date, solvent, concentration, volume [ ] Visual inspection: solution is clear and colorless [ ] Aliquots labeled with compound, concentration, date, freeze-thaw count [ ] First-use aliquot shows expected biological activity in pilot assay For information on what certificates of analysis should contain, see: Quality Testing and Third-Party Verification for IGF-1 LR3 Research Peptides
Specifically, BPC 157 accelerates tendon- and (Staresinic et al., 2003
For research use only not for human or veterinary use